The molecular background of sex difference in depressive disorders: still an enigma.
Becherer
Alexander
A
D000293:Adolescent; D000328:Adult; D003866:Depressive Disorder / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D010879:Piperazines / Q000737:chemistry; D049268:Positron-Emission Tomography; D011725:Pyridines / Q000737:chemistry; D044282:Receptor, Serotonin, 5-HT1A / Q000378:metabolism*; D012727:Sex Characteristics
D010879:Piperazines; D011725:Pyridines; D044282:Receptor, Serotonin, 5-HT1A; C090413:N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide
Neuropsychopharmacology. 2004 Dec;29(12):2258-65
15483563
Eur J Nucl Med Mol Imaging. 2008 Dec;35(12):2159-68
18542956
Am J Psychiatry. 2002 Jun;159(6):1051-2
12042198
Psychopharmacology (Berl). 2007 Dec;195(3):425-33
17874074
Int J Neuropsychopharmacol. 2008 Jun;11(4):465-76
17971260
Synapse. 2007 Jul;61(7):523-30
17447260
Arch Gen Psychiatry. 2000 Feb;57(2):174-80
10665620
Nucl Med Biol. 2000 Jul;27(5):499-507
10962258
Neuropsychopharmacology. 2006 Aug;31(8):1745-9
16395308
Brain Res. 2002 Nov 8;954(2):173-82
12414100
J Affect Disord. 2007 Sep;102(1-3):245-58
17092565
Neuroimage. 2008 Feb 1;39(3):1408-19
18036835
Biol Psychiatry. 2006 Jan 15;59(2):106-13
16154547